SCHEMBL30830711

SCHEMBL30830711

COc1cc(N2CCC3(CCN(C(=O)c4ccc([C@H]5C[C@@H](Nc6cnn(C)c(=O)c6Br)CN(C)C5)cc4)CC3)CC2)c(F)cc1C1CCC(=O)NC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 8/20 0.44
▸ BRD9 Q9H8M2 4/20 0.44
▸ BRD1 O95696 1/20 0.44
▸ ACHE P22303 1/20 0.44
▸ BRPF1 P55201 1/20 0.44
▸ BPTF Q12830 1/20 0.44
▸ KAT2A Q92830 1/20 0.44
▸ BRD7 Q9NPI1 1/20 0.44
▸ BAZ2B Q9UIF8 1/20 0.44
▸ BRPF3 Q9ULD4 1/20 0.44
▸ CRBN Q96SW2 1/20 0.32
▸ IKZF3 Q9UKT9 1/20 0.32
▸ PDE5A O76074 3/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ CD274 Q9NZQ7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30831030 0.94 KAT2B (0.44) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831100 0.93 KAT2B (0.44) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830929 0.93 KAT2B (0.45) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830989 0.90 KAT2B (0.45) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831061 0.90 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830658 0.90 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831012 0.89 KAT2B (0.44) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830649 0.89 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831016 0.88 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830854 0.88 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback